Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 738241, 13 pages
http://dx.doi.org/10.1155/2015/738241
Research Article

Heteronemin, a Spongean Sesterterpene, Induces Cell Apoptosis and Autophagy in Human Renal Carcinoma Cells

1Pharmacological Institute, College of Medicine, National Taiwan University, No. 1 Jen-Ai Road, Section 1, Taipei 10051, Taiwan
2Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan
3National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan
4The Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, No. 250 Wu-Hsing Street, Taipei 11031, Taiwan
5Department of Pharmacology, College of Medicine, Taipei Medical University, No. 250 Wu-Hsing Street, Taipei 110311, Taiwan

Received 23 July 2014; Accepted 26 August 2014

Academic Editor: Chin-Chung Wu

Copyright © 2015 Szu-Ying Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. H. Sarkar, Y. Li, Z. Wang, and D. Kong, “Cellular signaling perturbation by natural products,” Cellular Signalling, vol. 21, no. 11, pp. 1541–1547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Zidane, P. Pondaven, C. Roussakis, and M.-T. More, “Effects in vitro of pachymatismin, a glycoprotein from the marine sponge Pachymatisma johnstonii, on a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6),” Anticancer Research, vol. 16, no. 5, pp. 2805–2812, 1996. View at Google Scholar · View at Scopus
  3. R. Mutter and M. Wills, “Chemistry and clinical biology of the bryostatins,” Bioorganic and Medicinal Chemistry, vol. 8, no. 8, pp. 1841–1860, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. G. R. Pettit, C. L. Herald, and Y. Kamano, “Structure of the Bugula neritina (marine bryozoa) antineoplastic component bryostatin 3,” Journal of Organic Chemistry, vol. 48, no. 26, pp. 5354–5356, 1983. View at Publisher · View at Google Scholar · View at Scopus
  5. G. R. Pettit, C. L. Herald, Y. Kamano, D. Gust, and R. Aoyagi, “The structure of bryostatin 2 from the marine Bryozoan Bugula neritina,” Journal of Natural Products, vol. 46, no. 4, pp. 528–531, 1983. View at Publisher · View at Google Scholar · View at Scopus
  6. P.-C. Chiang, C.-L. Chien, S.-L. Pan et al., “Induction of endoplasmic reticulum stress and apoptosis by a marine prostanoid in human hepatocellular carcinoma,” Journal of Hepatology, vol. 43, no. 4, pp. 679–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-N. Wonganuchitmeta, S. Yuenyongsawad, N. Keawpradub, and A. Plubrukarn, “Antitubercular sesterterpenes from the Thai sponge Brachiaster sp,” Journal of Natural Products, vol. 67, no. 10, pp. 1767–1770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H. N. Kamel, Y. B. Kim, J. M. Rimoldi, F. R. Fronczek, D. Ferreira, and M. Slattery, “Scalarane sesterterpenoids: semisynthesis and biological activity,” Journal of Natural Products, vol. 72, no. 8, pp. 1492–1496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kopf, K. Viola, A. G. Atanasov et al., “In vitro characterisation of the anti-intravasative properties of the marine product heteronemin,” Archives of Toxicology, vol. 87, no. 10, pp. 1851–1861, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schumacher, C. Cerella, S. Eifes et al., “Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death,” Biochemical Pharmacology, vol. 79, no. 4, pp. 610–622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Mizushima, Y. Ohsumi, and T. Yoshimori, “Autophagosome formation in mammalian cells,” Cell Structure and Function, vol. 27, no. 6, pp. 421–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kirkegaard, M. P. Taylor, and W. T. Jackson, “Cellular autophagy: surrender, avoidance and subversion by microorganisms,” Nature Reviews Microbiology, vol. 2, no. 4, pp. 301–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Münz, “Autophagy and antigen presentation,” Cellular Microbiology, vol. 8, no. 6, pp. 891–898, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Levine and D. J. Klionsky, “Development by self-digestion: molecular mechanisms and biological functions of autophagy,” Developmental Cell, vol. 6, no. 4, pp. 463–477, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Levine and J. Yuan, “Autophagy in cell death: an innocent convict?” Journal of Clinical Investigation, vol. 115, no. 10, pp. 2679–2688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. H. Baehrecke, “Autophagy: dual roles in life and death?” Nature Reviews Molecular Cell Biology, vol. 6, no. 6, pp. 505–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Lockshin and Z. Zakeri, “Caspase-independent cell deaths,” Current Opinion in Cell Biology, vol. 14, no. 6, pp. 727–733, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Eisenberg-Lerner, S. Bialik, H. U. Simon, and A. Kimchi, “Life and death partners: apoptosis, autophagy and the cross-talk between them,” Cell Death and Differentiation, vol. 16, no. 7, pp. 966–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. McCubrey, M. M. LaHair, and R. A. Franklin, “Reactive oxygen species-induced activation of the MAP kinase signaling pathways,” Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1775–1789, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Torii, T. Yamamoto, Y. Tsuchiya, and E. Nishida, “ERK MAP kinase in G1 cell cycle progression and cancer,” Cancer Science, vol. 97, no. 8, pp. 697–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Dhillon, S. Hagan, O. Rath, and W. Kolch, “MAP kinase signalling pathways in cancer,” Oncogene, vol. 26, no. 22, pp. 3279–3290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Xia, M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg, “Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis,” Science, vol. 270, no. 5240, pp. 1326–1331, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Cuadrado and A. R. Nebreda, “Mechanisms and functions of p38 MAPK signalling,” Biochemical Journal, vol. 429, no. 3, pp. 403–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Azijli, S. Yuvaraj, I. Van Roosmalen et al., “MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1,” Apoptosis, vol. 18, no. 7, pp. 851–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Sun, D. Li, L. Wang et al., “C-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells,” Journal of Translational Medicine, vol. 9, no. 1, article 161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. H. West and S. T. Sweeney, “Oxidative stress and autophagy: mediators of synapse growth?” Autophagy, vol. 8, no. 2, pp. 284–285, 2012. View at Google Scholar · View at Scopus
  28. P. Haberzettl and B. G. Hill, “Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response,” Redox Biology, vol. 1, no. 1, pp. 56–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. C. Yu, P. C. Chiang, P. H. Lu et al., “Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells,” Journal of Nutritional Biochemistry, vol. 23, no. 8, pp. 900–907, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Y. Wu, S. L. Pan, T. H. Chen et al., “YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway,” The British Journal of Pharmacology, vol. 155, no. 4, pp. 505–513, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. N. Danial and S. J. Korsmeyer, “Cell death: critical control points,” Cell, vol. 116, no. 2, pp. 205–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. D. Newmeyer and S. Ferguson-Miller, “Mitochondria: releasing power for life and unleashing the machineries of death,” Cell, vol. 112, no. 4, pp. 481–490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Jiang and X. Wang, “Cytochrome C-mediated apoptosis,” Annual Review of Biochemistry, vol. 73, no. 1, pp. 87–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. E. F. Wagner and Á. R. Nebreda, “Signal integration by JNK and p38 MAPK pathways in cancer development,” Nature Reviews Cancer, vol. 9, no. 8, pp. 537–549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Hu, J. Han, B. Zhai et al., “Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation,” Apoptosis, vol. 19, no. 1, pp. 210–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. D. J. Klionsky, H. Abeliovich, P. Agostinis et al., “Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes,” Autophagy, vol. 4, no. 2, pp. 151–175, 2008. View at Publisher · View at Google Scholar
  37. I. Dikic, T. Johansen, and V. Kirkin, “Selective autophagy in cancer development and therapy,” Cancer Research, vol. 70, no. 9, pp. 3431–3434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. D. S. R. D. S. Bhakuni, Bioactive Marine Natural Products, Springer, Amsterdam, The Netherlands, 2005.
  39. D. Sipkema, M. C. R. Franssen, R. Osinga, J. Tramper, and R. H. Wijffels, “Marine sponges as pharmacy,” Marine Biotechnology, vol. 7, no. 3, pp. 142–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Garrido, L. Galluzzi, M. Brunet, P. E. Puig, C. Didelot, and G. Kroemer, “Mechanisms of cytochrome c release from mitochondria,” Cell Death and Differentiation, vol. 13, no. 9, pp. 1423–1433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. K. Brunelle and A. Letai, “Control of mitochondrial apoptosis by the Bcl-2 family,” Journal of Cell Science, vol. 122, no. 4, pp. 437–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Rasmussen and W. K. Rathmell, “Looking beyond inhibition of VEGF/mTOR: emerging targets for renal cell carcinoma drug development,” Current Clinical Pharmacology, vol. 6, no. 3, pp. 199–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. I. R. Konings, J. Verweij, E. A. Wiemer, and S. Sleijfer, “The applicability of mTOR inhibition in solid tumors,” Current Cancer Drug Targets, vol. 9, no. 3, pp. 439–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. G. R. Hudes, “Targeting mTOR in renal cell carcinoma,” Cancer, vol. 115, no. 10, pp. 2313–2320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. P. J. Wysocki, “MTOR in renal cell cancer: modulator of tumor biology and therapeutic target,” Expert Review of Molecular Diagnostics, vol. 9, no. 3, pp. 231–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Morgensztern and H. L. McLeod, “PI3K/Akt/mTOR pathway as a target for cancer therapy,” Anti-Cancer Drugs, vol. 16, no. 8, pp. 797–803, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Shaw and L. C. Cantley, “Ras, PI(3)K and mTOR signalling controls tumour cell growth,” Nature, vol. 441, no. 7092, pp. 424–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. B. T. Hennessy, D. L. Smith, P. T. Ram, Y. Lu, and G. B. Mills, “Exploiting the PI3K/AKT pathway for cancer drug discovery,” Nature Reviews Drug Discovery, vol. 4, no. 12, pp. 988–1004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. O. N. Ozes, L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner, “NF-κB activation by tumour necrosis factor requires tie Akt serine- threonine kinase,” Nature, vol. 401, no. 6748, pp. 82–85, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. L.-H. Zhang, Y.-L. Jia, X.-X. Lin et al., “AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species,” Biochimica et Biophysica Acta—General Subjects, vol. 1830, no. 8, pp. 4148–4159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. C. J. Hsieh, P. L. Kuo, Y. C. Hsu, Y. F. Huang, E. M. Tsai, and Y. L. Hsu, “Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation,” Free Radical Biology and Medicine, vol. 67, pp. 159–170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. J. Yang, C. E. Chee, S. Huang, and F. A. Sinicrope, “The role of autophagy in cancer: therapeutic implications,” Molecular Cancer Therapeutics, vol. 10, no. 9, pp. 1533–1541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Li and D. E. Johnson, “Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation,” Cancer Letters, vol. 314, no. 1, pp. 102–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Zhou, Y. Yang, and D. Xing, “Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis,” FEBS Journal, vol. 278, no. 3, pp. 403–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Lorin, G. Pierron, K. M. Ryan, P. Codogno, and M. Djavaheri-Mergny, “Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy,” Autophagy, vol. 6, no. 1, pp. 153–154, 2010. View at Publisher · View at Google Scholar · View at Scopus